P. Milner

Plasma and red blood cell membrane accretion and pharmacokinetics of RT001 (bis-allylic 11,11-D2-linoleic acid ethyl ester) during long term dosing in patients.

M. Shchepinov, J. Brenna, L. V. D. van der Ploeg, 2020, Journal of pharmaceutical sciences.

RT001 in Progressive Supranuclear Palsy—Clinical and In-Vitro Observations

M. Shchepinov, P. Angelova, P. Atwal, 2021, Antioxidants.

The natural history of infantile neuroaxonal dystrophy

F. Alkuraya, M. Salih, P. Atwal, 2019, Orphanet Journal of Rare Diseases.

The infantile neuroaxonal dystrophy rating scale (INAD-RS)

D. Adams, P. Atwal, Darius J. Adams, 2020, Orphanet Journal of Rare Diseases.

An expanded access protocol of RT001 in amyotrophic lateral sclerosis—Initial experience with a lipid peroxidation inhibitor

S. Paganoni, M. Cudkowicz, J. Berry, 2022, Muscle & nerve.

Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases

M. Shchepinov, D. Adams, P. Atwal, 2020, JIMD reports.

Double blind trial of a deuterated form of linoleic acid (RT001) in Friedreich ataxia

S. Subramony, S. Perlman, K. Mathews, 2022, Journal of Neurology.

Only 20-25% Deuteration of Polyunsaturated Fatty Acids Prevents Lipid Peroxidation.

P. Atwal, M. Midei, P. Milner, 2020, Trends in Molecular Medicine.